What is Emergent Biosolutions's revenue?

Emergent Biosolutions (EBS) generated $676.8M in revenue over the trailing twelve months, down 29.9% year over year.

Is Emergent Biosolutions profitable?

Emergent Biosolutions reported $114.0M in net income over the trailing twelve months, a 9.6% net margin.

What are Emergent Biosolutions's profit margins?

Gross margin is 54.2% and operating margin is 15.0%, with a 9.6% net margin.

What is Emergent Biosolutions's earnings per share?

Emergent Biosolutions's diluted EPS over the trailing twelve months is $1.95.

Where does Emergent Biosolutions's income statement data come from?

Every line is extracted from Emergent Biosolutions's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Emergent Biosolutions EBS Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$676.8M-8.9%	$742.9M-5.8%	$788.9M-7.4%	$851.6M-11.8%	$965.4M-7.5%
Total cost of revenue	$309.7M-5.1%	$326.2M-9.2%	$359.3M-9.3%	$396M-36.7%	$625.2M-8.2%
Gross profit	$367.1M-11.9%	$416.7M-3.0%	$429.6M-5.7%	$455.6M+33.9%	$340.2M-6.1%
Gross margin	54.2%-1.9pp	56.1%+1.6pp	54.5%+1.0pp	53.5%+18.3pp	35.2%+0.5pp
Research and development	$48.6M-8.6%	$53.2M+6.0%	$50.2M-0.6%	$50.5M-28.6%	$70.7M0.0%
Selling, general and administrative	$180.3M-3.1%	$186.1M-5.0%	$195.8M-16.1%	$233.5M-15.3%	$275.7M-10.5%
Depreciation and amortization	$65.3M+0.3%	$65.1M0.0%	$65.1M0.0%	$65.1M-0.2%	$65.2M+0.2%
Total costs & expenses	$616.1M-4.2%	$642.8M-4.1%	$670.4M-10.0%	$745.1M-30.0%	$1.06B-7.7%
Operating income	——	——	$118.5M+11.3%	$106.5M+208%	-$98.6M+9.3%
Interest expense	$55.6M-6.2%	$59.3M-0.2%	$59.4M+13.1%	$52.5M-14.5%	$61.4M-13.5%
Other income (expense), net	-$57.2M-231%	-$17.3M-37.3%	-$12.6M-115%	$84.2M+132%	$36.3M+206%
Gain (loss) on disposal of assets	$12.2M—	$0+100%	-$12.2M-123%	$52.1M+331%	$12.1M-50.2%
Income before income taxes	——	——	$105.9M-44.5%	$190.7M+406%	-$62.3M+56.4%
Income tax expense	$12.1M-59.9%	$30.2M+0.7%	$30M-41.4%	$51.2M-26.1%	$69.3M+45.3%
Net income	——	——	$75.9M-45.6%	$139.5M+206%	-$131.6M+31.0%
Diluted earnings per share	——	——	$1.31-46.7%	$2.46+191%	-$2.70+27.4%
Basic earnings per share	——	——	$1.42-45.8%	$2.62+203%	-$2.54+29.8%
Weighted-average shares, diluted	223.9M-0.4%	224.7M+1.7%	221M+0.4%	220.1M+0.7%	218.5M+2.4%
Weighted-average shares, basic	212.8M-1.2%	215.3M+0.2%	214.8M0.0%	214.7M+0.8%	213.1M+1.0%
Amortization of capitalized software and acquired intangible assets	$65.3M+0.3%	$65.1M0.0%	$65.1M0.0%	$65.1M-0.2%	$65.2M+0.2%
Gain in connection with sale	——	——	——	——	——
Other income, net (Note 6)	——	——	——	——	——
Revenue From Contract With Customer Excluding Assessed Tax	$676.8M-8.9%	$742.9M-5.8%	$788.9M-7.4%	$851.6M-11.8%	$965.4M-7.5%
EBIT	——	——	$118.5M+11.3%	$106.5M+208%	-$98.6M+9.3%
EBITDA	——	——	$216.8M+4.3%	$207.8M+2,599%	$7.7M+7,600%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Emergent Biosolutions.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Emergent Biosolutions's revenue?: Emergent Biosolutions (EBS) generated $676.8M in revenue over the trailing twelve months, down 29.9% year over year.
Is Emergent Biosolutions profitable?: Emergent Biosolutions reported $114.0M in net income over the trailing twelve months, a 9.6% net margin.
What are Emergent Biosolutions's profit margins?: Gross margin is 54.2% and operating margin is 15.0%, with a 9.6% net margin.
What is Emergent Biosolutions's earnings per share?: Emergent Biosolutions's diluted EPS over the trailing twelve months is $1.95.
Where does Emergent Biosolutions's income statement data come from?: Every line is extracted from Emergent Biosolutions's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.